| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to medicine, namely to therapeutic agents used for treating ischemic cardiac disorders, and describes a combined medicine as a thrombocyte aggregation inhibitor containing an agent presented by a combination of clopidogrel or a pharmaceutically acceptable salt thereof, acetyl salicylic acid and magnesium hydroxide and additives.EFFECT: invention provides enlarging the list of medicines and preparing the new combination of the agents possessing activity on platelet aggregation and the property to protect the gastric mucosa, as well as enhancing the clinical effectiveness of the medicine and prolonging its action.13 cl, 3 tbl, 1 ex |
